Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research and Development Expenses

v3.20.1
Research and Development Expenses
 12 Months Ended
Dec. 31, 2019
Research And Development Expenses  
RESEARCH AND DEVELOPMENT EXPENSES

NOTE 15:-  RESEARCH AND DEVELOPMENT EXPENSES

 

   

Year ended December 31,

  
    2019     2018     2017  
    USD  
                   
Clinical and preclinical trials   $ 10,290     $ 4,768     $ 3,809  
Salary and related expenses     814       909       888  
Patents     163       229       234  
Royalties     11       14       11  
Laboratory materials     40       73       63  
Rent     51       51       51  
Depreciation     5       3       3  
Others     (398 )     28       47  
                         
    $ 10,976     $ 6,075     $ 5,106